How do I interpret my genomic profiling results for Leukemia
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Understanding Your Genomic Profiling Results for Leukemia
Genomic profiling is one of the most important tests for leukemia because it reveals the specific genetic changes in your cancer cells. This information directly guides your treatment plan. Let me walk you through how to interpret these results.
What Genomic Profiling Actually Does
According to the NCCN Guidelines for Patients: Acute Myeloid Leukemia, genomic profiling (also called molecular testing, tumor profiling, or genetic testing) looks for changes only in your leukemia cells—not in your healthy cells or inherited genes. Think of it like a detailed fingerprint of your cancer that helps doctors understand what makes your specific leukemia unique.
Types of Genetic Changes Your Results Might Show
Your report may describe several types of changes:
Deletions – When a piece of a chromosome or gene is missing (written as "del(5q)" for example)
Insertions – When a new piece of chromosome or gene is added
Translocations – When pieces of two different chromosomes swap places (written as "t(8;21)" or described as a gene rearrangement like "RUNX1::RUNX1T1")
Inversions – When a section of a chromosome flips and reattaches backwards (like "inv(16)")
Point mutations – When a single part of a gene is changed
Amplifications – When a gene or chromosome piece is duplicated or increased
How These Results Guide Your Care
According to NCCN Guidelines, these genetic findings serve three critical purposes:
-
Determine your AML subtype – Different genetic changes define different subtypes of leukemia, each with different treatment approaches
-
Predict prognosis – Certain mutations help doctors understand how aggressive your leukemia might be and how it may respond to treatment
-
Target treatment selection – Some mutations respond to specific targeted therapies (drugs designed to attack that particular genetic change), while others are treated with chemotherapy or other approaches
What You Might See on Your Report
Your genomic profiling report may include results from several testing methods:
Karyotype – A picture of all your chromosomes showing if any are extra, missing, rearranged, or abnormal
FISH (Fluorescence In Situ Hybridization) – A specialized test that uses colored dyes to find specific genetic changes that might be too small to see under a regular microscope
NGS (Next-Generation Sequencing) – A detailed method that reads your DNA sequence and can find mutations other tests might miss
PCR (Polymerase Chain Reaction) – A sensitive test that can find 1 abnormal cell among more than 100,000 normal cells; particularly useful for monitoring treatment response
Important Context: Risk Groups
The NCCN Guidelines explain that your genetic results help place you into a risk group (favorable, intermediate, or adverse). This classification, combined with your age and overall health, helps your doctor plan your specific treatment approach. Different genetic changes carry different implications for how well treatment might work.
Questions to Ask Your Healthcare Team
To get the most from your genomic profiling results, consider asking:
-
"What specific genetic changes were found in my leukemia cells, and what do they mean for my treatment options?"
-
"Based on my genetic results, what risk group am I in, and what does that tell us about my prognosis?"
-
"Are there targeted therapies available for my specific genetic changes, or will I be treated with chemotherapy?"
-
"Will my genetic results be monitored during treatment to see how well the therapy is working?"
-
"Are there any clinical trials available for my specific genetic subtype of leukemia?"
A Critical Reminder
While genomic profiling provides essential information, your oncologist will interpret these results in the context of your complete clinical picture—your age, overall health, performance status, and other test results. The genetic findings are one important piece of a larger puzzle that guides your personalized treatment plan.
According to the NCCN Guidelines, it's important to have regular conversations with your care team about what these results mean for YOUR specific situation and what treatment approach they recommend based on all your information together.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Acute Myeloid Leukemia (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for Leukemia patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: